Title : MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway.

Pub. Date : 2021 Jan 18

PMID : 33462219






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway. Epirubicin AKT serine/threonine kinase 1 Homo sapiens